Efficacy and safety of follitropin alfa/lutropin alfa in ART: a randomized controlled trial in poor ovarian responders

Hum Reprod. 2017 Jul 1;32(7):1537-1538. doi: 10.1093/humrep/dex208.

Authors

P Humaidan^{1

2}, W Chin³, D Rogoff⁴, T D'Hooghe⁵, S Longobardi⁵, J Hubbard⁴, J Schertz⁴

Affiliations

¹ The Fertility Clinic, Skive Regional Hospital, Skive, Denmark.
² Faculty of Health, Aarhus University, Aarhus, Denmark.
³ Global Biostatistics and Epidemiology, EMD Serono, Billerica, MA, USA, a business of Merck KGaA, Darmstadt, Germany.
⁴ Global Clinical Development, EMD Serono Research and Development Institute, Billerica, MA, USA, a business of Merck KGaA, Darmstadt, Germany.
⁵ Global Medical Affairs Fertility, Merck KGaA, Darmstadt, Germany.

No abstract available

Publication types

Published Erratum